NITRIC-OXIDE INHIBITS LPS-INDUCED IL-6 PRODUCTION IN ENTEROCYTES

被引:22
|
作者
MEYER, TA
TIAO, GM
JAMES, JH
NOGUCHI, Y
OGLE, CK
FISCHER, JE
HASSELGREN, PO
机构
[1] UNIV CINCINNATI,MED CTR,COLL MED,DEPT SURG,CINCINNATI,OH 45267
[2] SHRINERS BURNS INST,CINCINNATI,OH
关键词
D O I
10.1006/jsre.1995.1090
中图分类号
R61 [外科手术学];
学科分类号
摘要
In recent studies, production of interleukin-6 (IL-6) in cultured enterocytes was stimulated by lipolysaccharide (LPS). In other cell types, IL-6 production was inhibited by nitric oxide (NO). We tested the hypothesis that LPS-induced IL-6 production in the enterocyte is regulated, at least in part, by NO. IEC-6 cells (a rat intestinal epithelial cell line) were cultured for 3 days with different combinations of LPS (1-10 mu g/ml), the NO synthase inhibitor N-omega-nitro-L-arginine (NNA, 3-300 mu M), L-arginine (10 mM), the NO donor sodium nitroprusside (SNP, 0.5-1 mu M), or medium alone as control. IL-6 levels in the culture medium were determined by the B9 murine hybridoma bioassay. Nitrite, a stable end product of NO metabolism, was measured by HPLC. PCR was performed to determine inducible NO synthase (iNOS) mRNA expression in the IEC-6 cells. Treatment of IEC-6 cells with LPS stimulated IL-6 production. LPS-induced IL-6 production was further increased by NNA in a dose-dependent fashion. This effect of NNA was abolished by the addition of L-arginine. SNP caused a dose-dependent decrease in IL-6 production. Nitrite production was increased in a dose-dependent fashion after LPS treatment. PCR revealed an increase in iNOS mRNA expression in IEC-6 cells after administration of 1 mu g/ml LPS. The results suggest that NO inhibits LPS-induced IL-6 production in the enterocyte. NO may be an important regulator of intestinal cytokine response during sepsis and endotoxemia. (C) 1995 Academic Press, Inc.
引用
收藏
页码:570 / 575
页数:6
相关论文
共 50 条
  • [41] Inhibition of nitric oxide production rescues LPS-induced fetal abortion in mice
    Athanassakis, I
    Aifantis, I
    Ranella, A
    Giouremou, K
    Vassiliadis, S
    NITRIC OXIDE-BIOLOGY AND CHEMISTRY, 1999, 3 (03): : 216 - 224
  • [42] Epinephrine and norepinephrine enhance LPS-induced nitric oxide (NO) production in macrophages.
    Chi, DS
    Oui, M
    Krishnaswamy, G
    Li, C
    Kelley, J
    Smith, JK
    Stone, W
    FASEB JOURNAL, 2000, 14 (06): : A1229 - A1229
  • [43] Inhibition of LPS-induced nitric oxide production in RAW cells by radioprotective thiols
    Kumar, KS
    Singh, VK
    Jackson, W
    Seed, TM
    EXPERIMENTAL AND MOLECULAR PATHOLOGY, 2003, 74 (01) : 68 - 73
  • [44] LPS-INDUCED RELEASE OF IL-6 MODULATES PRODUCTION OF TNFA AND IL-1β IN A JAK2-DEPENDENT MANNER
    Minogue, A. M.
    Barrett, J. P.
    Lynch, M. A.
    GLIA, 2011, 59 : S144 - S144
  • [45] The β-adrenoceptor agonist clenbuterol is a potent inhibitor of the LPS-induced production of TNF-α and IL-6 in vitro and in vivo
    Izeboud, CA
    Monshouwer, M
    van Miert, ASJPAM
    Witkamp, RF
    INFLAMMATION RESEARCH, 1999, 48 (09) : 497 - 502
  • [46] LPS-induced MCP-1 and IL-6 production is not reversed by oestrogen in human periodontal ligament cells
    Jonsson, Daniel
    Nebel, Daniel
    Bratthall, Gunilla
    Nilsson, Bengt-Olof
    ARCHIVES OF ORAL BIOLOGY, 2008, 53 (09) : 896 - 902
  • [47] Lipophilic Statins Suppress LPS-induced IL-6 Production in Macrophages Through Inhibition of the Mevalonic Acid Pathway
    Ako, S.
    Chang, H.
    Hernandez, A.
    Massoumi, R.
    Sinnett-Smith, J.
    King, J.
    Hines, O. J.
    Rozengurt, E.
    Eibl, G.
    PANCREAS, 2019, 48 (10) : 1402 - 1402
  • [48] Bmx regulates LPS-induced IL-6 and VEGF production via mRNA stability in rheumatoid synovial fibroblasts
    Palmer, Christine D.
    Mutch, Brenda E.
    Page, Theresa H.
    Horwood, Nicole J.
    Foxwell, Brian M. J.
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2008, 370 (04) : 599 - 602
  • [49] Glucose transporter 4 mediates LPS-induced IL-6 production in osteoblasts under high glucose conditions
    Kato, Shunichiro
    Tanabe, Natsuko
    Nagao, Mayu
    Sekino, Jumpei
    Tomita, Keiko
    Sakai, Mayu
    Abe, Kimiko
    Suzuki, Naoto
    Ueda, Koichiro
    JOURNAL OF ORAL SCIENCE, 2020, 62 (04) : 423 - 426
  • [50] The β-adrenoceptor agonist clenbuterol is a potent inhibitor of the LPS-induced production of TNF-α and IL-6 in vitro and in vivo
    C. A. Izeboud
    M. Monshouwer
    A. S. J. P. A. M. van Miert
    R. F. Witkamp
    Inflammation Research, 1999, 48 : 497 - 502